Abstract
Enormous progress has recently been made in the characterization of the biochemical and molecular events associated with the control of the mammalian cell cycle and with cell replication. Some of the normal cellular genes engaged in such regulatory functions have been shown to lead to, or be associated with, aberrant growth of cells and to the development of the neoplastic changes in the cells. There are at least two kinds of genes associated with the aberrant growth properties of tumor cells (Bishop 1991). Mutated, activated forms of the normal cellular proto-oncogenes are able to cause neoplastic transformation of cells by disrupting the normal controlled mechanisms of cell replication and growth. Their gene products can be imagined to provide positive stimuli to cellular growth. The presence of a single mutated allele is sufficient to cause cell transformation, and the continued presence and expression of the other, wild- type allele is insufficient for the maintenance of the normal cellular phenotype (Fig. 1). Potential therapeutic approaches toward the genetic reversal of these kinds of defects might include interference with translation of oncogene messenger RNAs by the introduction of anti-sense sequences or ribozymes specific for the oncogene transcript, the introduction of transdominant wild-type alleles or the introduction of non-allelic genes encoding functions that interfere with the transforming function of the oncogene (Fig. 2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bartek J, Iggo R, Lane DP (1990) Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. Oncogene 5:893–899
Bishop JM (1991) Molecular themes in oncogenesis. Cell 64:235–248
Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H (1990) Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated Rb gene. Science 247:712–715
Cavanee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL (1983) Expression of recessive alleles by chromosome mechanisms in retinoblastoma. Nature 305:779–784
Chang T, Yee J-K, Yeargin T, Friedman T, Haas M (1992) Suppression of acute lymphoblastic leukemia by the human p53 gene. Cancer Res 52:222–226
Chen, P-L, Chen Y, Bookstein R, Lee W-H (1990) Genetic mechanisms of tumor suppression by the human p53 gene. Science 250:1576–1580
Cheng J, Haas M (1990) Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 10:5502–5509
Fearon ER, Vogelstein B (1990) A genetic model for colorectal carcinogenesis. Cell 61:759–767
Harris H (1988) The analysis of malignancy by cell fusion: the position in 1988. Cancer Res 48:3302–3306
Haung H-J S, Yee J-K, Shew J-Y, Chen PI-L, Bookstein R, Friedmann T, Lee EY, HP, Lee W-H (1988) Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242:1563–1566
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350:427–428
Klein G (1987) The approaching era of the tumor suppressor genes. Science 238:1539–1545
Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823
Lane DP, Benchimol S (1990) p53: oncogene or anti-oncogene? Genes Dev 4:1–8
Levine AJ (1990) The p53 protein and its interactions with the oncogene products of the small DNA tumor viruses. Virology 177:419–426
Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, Friend SH (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233–1238
Marshall CJ (1991) Tumor suppressor genes. Cell 64:313–326
Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich SJ (1990) Negative growth regulation in a gliobastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166–6170
Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC, Vogelstein B (1989) Mutations in the p53 gene occur in diverse human tumor types. Nature 342:705–708
Stanbridge EJ (1990). Human tumor suppressor genes. Ann Rev Genet 24:615–657
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Friedmann, T. (1992). A Potential Approach to Gene Therapy of Cancer. In: Gage, F.H., Christen, Y. (eds) Gene Transfer and Therapy in the Nervous System. Research and Perspectives in Neurosciences. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84842-1_3
Download citation
DOI: https://doi.org/10.1007/978-3-642-84842-1_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84844-5
Online ISBN: 978-3-642-84842-1
eBook Packages: Springer Book Archive